The Use of Non-Prescribed Prescription Drugs and Substance Use Among College Students: A 9-Year Follow-Up Cohort Study.

alcohol drinking in college cannabis tobacco use of non-prescribed prescription drugs young adult

Journal

Frontiers in psychiatry
ISSN: 1664-0640
Titre abrégé: Front Psychiatry
Pays: Switzerland
ID NLM: 101545006

Informations de publication

Date de publication:
2020
Historique:
received: 27 03 2020
accepted: 11 08 2020
entrez: 16 11 2020
pubmed: 17 11 2020
medline: 17 11 2020
Statut: epublish

Résumé

The use of non-prescribed prescription drugs (NPPD) is common in post-modern societies and a significant proportion of youth consume NPPD concomitantly to other drugs. We studied the prevalence of this consumption among university students in Spain, and its relationship to different patterns of alcohol, tobacco, and cannabis use. A cohort study among university students (n=1,380) (2005-2015) was carried out. Students completed self-administered questionnaires at initial (n=1,363, 98.7%), at 2 years (n=875, 75%) and 9 years of follow-up (n=415, 30.5%). Consumption of medicines (last 15 days), risky alcohol consumption (RC), heavy episodic drinking (HED), and tobacco and cannabis use were measured. Multilevel logistic regressions for repeated measures were generated using consumption of medicines with or without medical prescription as dependent variables. Prevalence of RC, HED, tobacco and cannabis had significant reductions during the follow-up. The use of NPPD increased over time, from 35.5% and 33.3% at 18 and 22 years old, respectively, to 49.6% at 27 years old. The highest rates were found among cannabis, tobacco, RC and HED users. For females, cannabis and RC constitute signitifant risk factors for use of NPPD. Conversely, for males, tobacco and cannabis were risk factors for such use of medicines. Later onset of alcohol consumption constitutes a protective factor for females. Our results reveal high prevalence of NPDD among university students. Those who consume NPPD are -at the same time- more likely to be alcohol, tobacco, and cannabis users than those who take medication under prescription. Preventive strategies should be reinforced and focused on this target population to decrease these high levels of poly-consumption.

Identifiants

pubmed: 33192636
doi: 10.3389/fpsyt.2020.00880
pmc: PMC7481469
doi:

Types de publication

Journal Article

Langues

eng

Pagination

880

Informations de copyright

Copyright © 2020 Busto Miramontes, Moure-Rodriguez, Diaz-Geada, Carbia, Cadaveira and Caamaño-Isorna.

Références

Int J Environ Res Public Health. 2019 Aug 16;16(16):
pubmed: 31426271
Drug Alcohol Depend. 2015 Nov 1;156:254-260
pubmed: 26455553
Gac Sanit. 2016 Nov - Dec;30(6):438-443
pubmed: 27155789
Addict Behav. 2015 Apr;43:25-7
pubmed: 25541290
Pharmacoepidemiol Drug Saf. 2004 Jun;13(6):405-9
pubmed: 15170771
PLoS One. 2014 May 02;9(5):e96380
pubmed: 24789323
Postgrad Med. 2019 Jan;131(1):52-59
pubmed: 30415596
Neurosci Biobehav Rev. 2019 Aug;103:14-20
pubmed: 31121199
Drug Alcohol Depend. 2006 Oct 1;84(3):281-8
pubmed: 16621337
Drug Alcohol Depend. 2017 Sep 1;178:372-379
pubmed: 28704765
Traffic Inj Prev. 2017 Jan 2;18(1):1-2
pubmed: 27258209
J Pharm Policy Pract. 2018 Jan 16;11:1
pubmed: 29372061
JAMA Pediatr. 2016 Oct 1;170(10):971-978
pubmed: 27533915
Drug Alcohol Rev. 2007 May;26(3):295-9
pubmed: 17454019
Addiction. 1993 Jun;88(6):791-804
pubmed: 8329970
Gac Sanit. 2000 Jul-Aug;14(4):294-9
pubmed: 11094847
PLoS One. 2018 Apr 9;13(4):e0193741
pubmed: 29630657
J Stud Alcohol. 1993 Jan;54(1):54-60
pubmed: 8355500
Subst Use Misuse. 2015;50(13):1678-89
pubmed: 26576505
J Stud Alcohol. 2006 Jul;67(4):529-37
pubmed: 16736072
PLoS One. 2016 Nov 3;11(11):e0165514
pubmed: 27812131
BMC Pharmacol Toxicol. 2014 Jul 08;15:36
pubmed: 25001259
Pharm World Sci. 2009 Dec;31(6):656-63
pubmed: 19731070
J Stud Alcohol Drugs. 2015 Jan;76(1):5-20
pubmed: 25486389
Drug Alcohol Depend. 2016 May 1;162:3-25
pubmed: 26851986
Gac Sanit. 2014 Sep-Oct;28(5):376-80
pubmed: 24725631
Pediatrics. 2012 Apr;129(4):709-20
pubmed: 22392174
Int J Public Health. 2011 Jun;56(3):247-52
pubmed: 20978818
Clin Pharmacol Ther. 2010 Mar;87(3):267-9
pubmed: 20160746

Auteurs

Alicia Busto Miramontes (A)

CIBER de Epidemiología y Salud Pública (CIBERESP), Department of Public Health, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

Lucía Moure-Rodriguez (L)

CIBER de Epidemiología y Salud Pública (CIBERESP), Department of Public Health, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

Ainara Diaz-Geada (A)

CIBER de Epidemiología y Salud Pública (CIBERESP), Department of Public Health, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

Carina Carbia (C)

APC Microbiome Ireland, University College Cork, Cork, Ireland.

Fernando Cadaveira (F)

Department of Clinical Psychology and Psychobiology, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

Francisco Caamaño-Isorna (F)

CIBER de Epidemiología y Salud Pública (CIBERESP), Department of Public Health, Universidade de Santiago de Compostela, Santiago de Compostela, Spain.

Classifications MeSH